Perspective - (2025) Volume 9, Issue 1
Received: 26-Feb-2025, Manuscript No. rrms-25-168637;
Editor assigned: 28-Feb-2025, Pre QC No. P-168637;
Reviewed: 14-Mar-2025, QC No. Q-168637;
Revised: 19-Mar-2025, Manuscript No. R-168637;
Published:
26-Mar-2025
, DOI: 10.37421/2952-8127.2025.9.209
Citation: Khan, Bradeil. “Neuronal Function Restoration through Targeted Brain Repair Strategies.” Res Rep Med Sci 9 (2025): 209.
Copyright: © 2025 Khan B. This is an open-access article distributed under the
terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and
source are credited.
The brain is always at risk of injury, whether it is acute or chronic. The capacity for regeneration in the adult mammalian brain has long been thought to be severely limited when compared to other tissues such as the skin, liver, or intestines. As a result, the mammalian brain is unable to rebuild structures that have been lost due to harmful events such as ischemic stroke or traumatic brain injury. With acute or chronic injury, however, there is significant functional restoration due to the ability of surviving brain structures to take up at least some of the functions of destroyed tissues. This is seen, for example, in patients who have left-hemispheric strokes and may initially exhibit motor or sensory aphasi. About the neurovascular niche following a cardioembolic stroke, very little is known. Angiogenesis, neurogenesis, and synaptic plasticity are three processes linked to neurorepair that occur naturally in adult brains but can also be induced by endogenous neurorepair phenomena. In order to improve collateral circulation, angiogenesis is stimulated, which results in the formation of new vessels. Intrinsic genetic pathways, growth factors, and environmental factors all have a role in controlling neurogenesis. Blood arteries are tightly linked to the leading process of migrating neural progenitor cells (NPCs), suggesting that this connection gives the NPCs directional guidance. These results imply that blood arteries are crucial as a scaffold for NPC migration to the injured area of the brain [2,3].
The destiny potential of endogenous NSCs also allows for targeting NSCs to assist glial cell replacement and eventual brain repair, in addition to techniques aimed at enhancing endogenous neurogenesis for neuronal repair in the context of acute or chronic illness. Demyelination in the mouse SVZ, for example, has been shown to result in increased NSC-derived oligodendrocyte production, which may aid in the remyelination of the wounded brain following a lesion. Induced production of oligodendrocytes (which are not produced by DG NSCs under normal conditions) could be used to induce remyelination of the DG circuitry in a variety of demyelinating disorders, including multiple sclerosis and epilepsy.However, possible therapeutic techniques aimed at using endogenous NSCs for glial repair are still being developed, and more research is needed [4].
One of these is the SVZ, which lines the lateral ventricles and is where NSCs give birth to newborn cells that migrate along the rostral migratory stream into the olfactory bulb (OB), where they differentiate into several types of olfactory neurons. In the rodent brain, SVZ/OB neurogenesis is relatively active, whereas in the human brain, the neurogenic activity of the SVZ appears to be very low or non-existent. In contrast, the hippocampus DG, where NSCs give rise to DG granule cells throughout life, is the second major neurogenic region [5].
Google Scholar Cross Ref Indexed at
Google Scholar Cross Ref Indexed at
Google Scholar Cross Ref Indexed at
Google Scholar Cross Ref Indexed at
Research and Reports in Medical Sciences received 13 citations as per Google Scholar report